Clinical subtypes of psoriasis and their associated comorbidities in a Mexican population

被引:0
|
作者
Bermudez-Rodriguez, Samantha P. [1 ]
Malagon-Liceaga, Andrea [1 ]
Palafox-Romo, Rebeca [1 ]
Diaz-Sanchez, Veronica M. [1 ]
Lopez-Jimenez, Fanny C. [1 ]
Vilchis-Flores, Olivo E. [1 ]
Mendez-Flores, Silvia [1 ]
Dominguez-Cherit, Judith G. [1 ]
机构
[1] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Dermatol, Ciudad De Mexico, Mexico
来源
GACETA MEDICA DE MEXICO | 2024年 / 160卷 / 04期
关键词
Comorbidity; Epidemiology; Mexico; Psoriasis; Clinical types;
D O I
10.24875/GMM.24000215
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Psoriasis is an inflammatory, systemic, and chronic disease affecting 2.9% of Mexicans, It is associated with metabolic and inflammatory comorbidities. Objective: To determine the distribution of psoriasis subtypes and associated comorbidities in a tertiary hospital in Mexico City. Material and methods: Descriptive, observational, retrospective, and crosssectional study conducted on patients with psoriasis (1999-2023). Data collected included age, sex, subtype, year of diagnosis and death, disease progression, severity index (PASI), and comorbidities. Qualitative variables were described in frequencies and percentages; quantitative variables with mean and standard deviation. Logistic regression was performed to evaluate associations. Results: The study included 221 patients (116 men) with an average age of 55 years. Plaque psoriasis was the most frequent subtype (85%), and the main comorbidities were dyslipidemia (33%) and hypertension (33%). Men showed a higher proportion of plaque psoriasis (97% versus 75%), while women had more palmoplantar psoriasis (9.5% versus 0.9%). Conclusions: The association with metabolic and cardiovascular comorbidities highlights the need for multidisciplinary management and early detection. This study underscores the importance of researching psoriasis in Mexico to improve prevention and treatment and guide public health policies.
引用
收藏
页码:530 / 537
页数:8
相关论文
共 50 条
  • [1] Comorbidities and psoriasis. Impact on clinical practice
    Gerdes, S.
    Mrowietz, U.
    HAUTARZT, 2012, 63 (03): : 202 - +
  • [2] Multimorbidity of Psoriasis: A Large-Scale Population Study of Its Associated Comorbidities
    Almenara-Blasco, Manuel
    Gracia-Cazana, Tamara
    Poblador-Plou, Beatriz
    Laguna-Berna, Clara
    Carmona-Pirez, Jonas
    Navarro-Bielsa, Alba
    Prados-Torres, Alexandra
    Gimeno-Miguel, Antonio
    Gilaberte, Yolanda
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (02)
  • [3] Clinical Aspects and Comorbidities of Psoriasis
    Ayala, Fabio
    Ayala, Fabrizio
    JOURNAL OF RHEUMATOLOGY, 2009, 36 : 19 - 20
  • [4] Prevalence of comorbidities in atopic dermatitis and psoriasis in the French population
    Richard, M. -A.
    Sei, J. -F.
    Philippe, C.
    Taieb, C.
    Joly, P.
    Ezzedine, K.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2021, 148 (01): : 28 - 33
  • [5] Comorbidities in psoriasis
    Aurangabadkar, Sanjeev J.
    INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2013, 79 : S10 - S17
  • [6] Epidemiology and Immunopathogenesis of Psoriasis and Its Comorbidities
    Li H.
    Lee D.J.
    Current Dermatology Reports, 2018, 7 (4) : 321 - 329
  • [7] Pulmonary comorbidities in psoriasis are associated with a high risk of respiratory failure
    Tanimura, Kazuya
    Nouraie, Seyed Mehdi
    Chandra, Divay
    Nyunoya, Toru
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2023, 51 (06)
  • [8] A retrospective cohort study to evaluate the development of comorbidities, including psychiatric comorbidities, among a pediatric psoriasis population
    Paller, Amy S.
    Schenfeld, Jennifer
    Accortt, Neil A.
    Kricorian, Gregory
    PEDIATRIC DERMATOLOGY, 2019, 36 (03) : 290 - 297
  • [9] Epidemiology of comorbidities in psoriasis
    Naldi, Luigi
    Mercuri, Santo Raffaele
    DERMATOLOGIC THERAPY, 2010, 23 (02) : 114 - 118
  • [10] Update on Comorbidities in Psoriasis
    Andersson A.M.
    Skov L.
    Thyssen J.P.
    Egeberg A.
    Current Dermatology Reports, 2017, 6 (2) : 129 - 136